PBT-1033

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NamePBT-1033
Drug Alias NamePBT-1033PBT-2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsAlzheimer DiseaseHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwedenAustralia +[4
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPrana Biotechnology Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPrana Biotechnology Ltd
Active IndicationsN/A
Inactive IndicationsAlzheimer DiseaseHuntington Disease

Other Information

ATC CodeN/A
Related LinksWikipedia